Skip to Content

Asthma

Reviewed by: [Satya Narisety, MD – Board-Certified Allergist/Immunologist]

Affiliation: The Medical Group of New Jersey

Asthma is a chronic inflammatory disease of the airways that causes coughing, wheezing, and shortness of breath. Triggers include allergens, infections, exercise, and weather changes.

Our team works with patients to provide guideline-based care and a plan to address flare-ups quickly. With this, most patients achieve full control and prevent flare-ups.


Symptom Onset & Initial Evaluation

Symptoms may be intermittent or persistent and can worsen at night or during exercise. Common features include:

  • Wheezing or chest tightness
  • A cough that lingers after colds
  • Shortness of breath during activity or allergy exposure
  • Fatigue from disturbed sleep

Your allergist will review your triggers, medication use, and past hospital or ER visits, and perform a focused lung exam.


Diagnosis

Asthma is diagnosed using a combination of clinical evaluation and specialized testing to confirm airway inflammation and identify underlying triggers. Allergists typically use the following assessments:

  • Spirometry with bronchodilator response: Measures lung function and confirms reversible airflow obstruction, a key feature of asthma.
  • Fractional exhaled nitric oxide (FeNO) testing: Detects airway inflammation, helping to guide and monitor treatment response.
  • Allergy testing: Identifies specific allergic triggers—such as pollen, dust mites, or pet dander, that may worsen asthma symptoms.
  • Phenotyping: Classifies asthma into subtypes, such as allergic, eosinophilic, or exercise-induced, to help tailor therapy to your specific condition.

Treatment & Ongoing Management

Asthma management focuses on controlling inflammation, preventing flare-ups, and improving medication delivery. Your allergist at The Medical Group of New Jersey will tailor treatment based on your symptoms, triggers, and lung function results.

Rescue therapy:

  • Quick-relief inhalers (e.g., albuterol) provide fast symptom relief during wheezing, coughing, or shortness of breath.
  • Using a spacer device with your inhaler helps ensure the medicine reaches deep into the lungs, improving effectiveness and reducing side effects.

Controller therapy:

  • Inhaled corticosteroids (ICS): The cornerstone of long-term asthma control, reducing airway inflammation and preventing flare-ups.
  • Combination inhalers (ICS-LABA): Used as both daily maintenance and as-needed rescue therapy in select patients.
  • Add-on medications: Long-acting muscarinic antagonists (LAMA) or leukotriene modifiers may be prescribed if symptoms persist.

Biologic therapies:

  • Injectable medications that target specific immune pathways for patients with moderate to severe asthma, such as anti-IgE, anti-IL-5, or anti-IL-4R treatments.

Asthma Action Plan:

  • A personalized, written plan outlining daily medication use, symptom zones (green, yellow, red), and emergency steps, empowering patients to recognize and respond quickly to worsening symptoms.

Monitoring & Follow-Up

Patients are typically re-evaluated every 3 to 6 months. Follow-up includes checking lung function, inhaler technique, and medication adjustments. Managing environmental triggers and comorbidities like allergies or acid reflux is key to long-term success.